Use of an implantable vagus nerve stimulation device was safe and effective for treating RA among patients who previously failed treatment with at least 1 b/tsDMARD.
An international, phase 3 clinical trial led by investigators at Mass General Brigham could improve the treatment of a rare disease that can cause debilitating symptoms.
The use of biologic and targeted therapies for children with juvenile idiopathic arthritis (JIA) surpassed more typical therapies in recent years, according to researchers.
Significant enhancements will equip clinicians with even more diagnostic clarity in the treatment of patients with autoimmune diseaseCARLSBAD, Calif., Nov. 14, 2024 (GLOBE NEWSWIRE) -- Exagen Inc., a ...
Early detection and management of symptoms can prevent arthritis progression and limit joint pain and injury. Also lifestyle modifications such as physical exercise, healthy diet and cessation of ...